FindTrial
Sign In

C000705128

3 trials

Sponsors

Tanosaki Ryuji, Saito Sho, Sho Saito

Conditions

COVID-19 COVID-19COVID-19, Coronavirus disease COVID-19, coronavirus disease, SARS-CoV-2, 2019-nCoVcoronavirus disease 2019 COVID19 Plasma therapy Biobank Biobanking

Phase 3

An open-label, randomized, controlled trial to evaluate the efficacy of convalescent plasma therapy for COVID-19.
Active, not recruitingJPRN-jRCTs031200374
Sho SaitoCOVID-19 COVID-19
Start: 2021-02-25Target: 200Updated: 2026-06-29

Unknown Phase

COVIPLA-R
Active, not recruitingJPRN-jRCTs031200124
Saito ShoCOVID-19, Coronavirus disease COVID-19, coronavirus disease, SARS-CoV-2, 2019-nCoV
Start: 2020-10-01Target: 59Updated: 2026-06-29
COVID-CP Banking
Active, not recruitingJPRN-jRCT1030200279
Tanosaki Ryujicoronavirus disease 2019 COVID19 Plasma therapy Biobank Biobanking
Start: 2020-12-25Target: 100Updated: 2026-06-29